Researchers on track to deliver CAR-T cell therapy
A leading New Zealand research institute believes it is on track to deliver a cutting edge immunotherapy for blood cancer patients in the public system next year. But only if it can get government funding. Researchers at the Malaghan Institute are well into clinical trials of CAR-T cell therapy with 60 patients. The institute's Clinical Director, Doctor Robert Weinkove spoke to Lisa Owen.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.